Trial Profile

A Prospective Single Blind Randomised Controlled Study to Compare the Outcomes of Patients With Diabetes and Clinically Non-infected Neuro-ischaemic and Neuropathic Foot Ulcers Treated With and Without Oral Antibiotics.

Status: Recruiting

Phase of Trial: Phase IV

Latest Information Update: 18 Sep 2021

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Amoxicillin; Amoxicillin/clavulanic acid; Antibacterials; Ceftazidime; Ceftriaxone; Ciprofloxacin; Clarithromycin; Clindamycin; Cotrimoxazole; Doxycycline hyclate; Flucloxacillin; Linezolid; Metronidazole; Rifampicin; Sodium fusidate; Teicoplanin; Trimethoprim
Indications Bacterial infections; Diabetic foot ulcer
Focus Therapeutic Use
Acronyms KADFUT

24 Oct 2012 Status changed from not yet recruiting to recruiting as reported by European Clinical Trials Database record.
23 Aug 2011 New trial record
17 Aug 2011 Biomarkers information updated

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com